undamentalytics Newsletter

Blickenstaff Kim D: insider trades

Chief executive, Officer, Director at 2 companies we cover. 4 open-market purchases and 23 sales not made under a pre-set plan, reported from March 23, 2017 to November 22, 2024.

Would copying Blickenstaff Kim D’s purchases have beaten the S&P 500?

Too few purchases to judge. None of their purchases has 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. After their sales, the shares moved −9.8% against the index over 12 months on average (a negative figure means selling was the right call); 52% trailed it. None of their purchases could be priced, so there is no copy portfolio.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Blickenstaff Kim D: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 23 +1.3% −0.7% 52% 6 −0.59 0.58 No reliable evidence
Sales, 12 months after the report 23 −9.8% −18.1% 52% 6 −0.87 0.42 No reliable evidence
Sales, 12 months after the trade 23 −10.9% −3.4% 57% 6 −0.71 0.51 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Tandem Diabetes Care Inc TNDM Executive Chairman323March 23, 2017November 22, 2024
Nuvation Bio Inc. NUVB —10June 13, 2024June 13, 2024

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
November 22, 2024November 20, 2024 TNDM Sale $1,241,400 −27.0%−46.7%−43.4%
June 13, 2024June 11, 2024 NUVB Purchase $499,348 not yetnot yetnot yet
May 19, 2022May 17, 2022 TNDM Sale $999,897 −41.0%−67.2%−64.8%
September 3, 2021September 2, 2021 TNDM Sale $3,253,418 −0.7%−54.1%−48.4%
August 18, 2021August 16, 2021 TNDM Sale $5,448,083 +21.3%−53.4%−47.2%
August 16, 2021August 12, 2021 TNDM Sale $6,835,945 +17.9%−50.0%−46.4%
August 12, 2021August 10, 2021 TNDM Sale $344,144 +20.6%−46.0%−42.7%
August 10, 2021August 6, 2021 TNDM Sale $8,917,492 +26.7%−43.6%−38.6%
June 10, 2021June 8, 2021 TNDM Sale $3,349,328 +27.8%−28.8%−26.8%
March 17, 2021March 15, 2021 TNDM Sale $17,453,026 +3.8%+21.1%+10.5%
December 17, 2020December 15, 2020 TNDM Sale $9,520,629 −4.8%+37.5%+30.8%
December 15, 2020December 11, 2020 TNDM Sale $850,950 −2.2%+37.6%+16.8%
December 10, 2020December 9, 2020 TNDM Sale $1,504,307 −13.1%+16.8%+17.0%
December 3, 2020December 1, 2020 TNDM Sale $2,425,250 −10.3%+12.6%+4.2%
November 16, 2020November 12, 2020 TNDM Sale $1,795,756 −6.9%+16.1%−0.4%
November 12, 2020November 10, 2020 TNDM Sale $2,502,250 −6.0%+5.9%−3.4%
August 19, 2020August 18, 2020 TNDM Sale $3,958,492 −19.0%−30.5%−23.2%
August 12, 2020August 10, 2020 TNDM Sale $922,672 +0.2%−24.8%−30.5%
August 10, 2020August 6, 2020 TNDM Sale $30,051,434 +2.9%−28.3%−32.8%
January 31, 2020January 29, 2020 TNDM Sale $3,796,125 +20.2%+4.7%+2.8%
December 18, 2019December 16, 2019 TNDM Sale $11,970,491 +16.7%+31.2%+30.7%
August 30, 2019August 28, 2019 TNDM Sale $7,096,200 −10.2%+44.2%+34.9%
March 13, 2019March 11, 2019 TNDM Sale $12,990,444 −7.5%−18.1%+3.8%
November 7, 2018November 6, 2018 TNDM Sale $7,327,787 +20.5%+38.1%+46.7%
February 13, 2018February 9, 2018 TNDM Purchase $1,500,000 not yetnot yetnot yet
October 17, 2017October 13, 2017 TNDM Purchase $999,950 not yetnot yetnot yet
March 23, 2017March 23, 2017 TNDM Purchase $2,000,000 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Blickenstaff Kim D traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.